Ruth Luthi-Carter

Ruth Luthi-Carter publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Ruth Luthi-Carter sits on this spectrum.

Ruth Luthi-Carter D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Ruth Luthi-Carter sits on this spectrum.

Best Publications

• Regional and cellular gene expression changes in human Huntington's disease brain.

  Angela Kaye Hodges;Andrew D. Strand;Aaron K. Aragaki;Alexandre Kuhn

  951
  Citations

• Decreased expression of striatal signaling genes in a mouse model of Huntington’s disease

  Ruth Luthi-Carter;Andrew Strand;Nikki L. Peters;Steven M. Solano

  881
  Citations

• Histone Deacetylase Inhibition by Sodium Butyrate Chemotherapy Ameliorates the Neurodegenerative Phenotype in Huntington's Disease Mice

  Robert J. Ferrante;James K. Kubilus;Junghee Lee;Hoon Ryu

  848
  Citations

• Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain

  Ruth Luthi-Carter;Sarah A. Hanson;Andrew D. Strand;Donald A. Bergstrom

  460
  Citations

• SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis

  Ruth Luthi-Carter;David M. Taylor;Judit Pallos;Emmanuel Lambert

  393
  Citations

• Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets

  Mali Jiang;Jiawei Wang;Jiawei Wang;Jinrong Fu;Lin Du

  368
  Citations

• Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease.

  Paolo Guidetti;Ruth E Luthi-Carter;Sarah J Augood;Robert Schwarcz

  351
  Citations

• Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects

  Ruth Luthi-Carter;Andrew D. Strand;Sarah A. Hanson;Charles Kooperberg

  312
  Citations

• Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage

  Alexandre Kuhn;Darlene R. Goldstein;Angela Hodges;Angela Hodges;Andrew D. Strand

  312
  Citations

• Population-specific expression analysis (PSEA) reveals molecular changes in diseased brain

  Alexandre Kuhn;Doris Thu;Henry J Waldvogel;Richard L M Faull

  289
  Citations

• Sustained effects of nonallele-specific Huntingtin silencing†

  Valérie Drouet;Valérie Drouet;Valérie Perrin;Raymonde Hassig;Raymonde Hassig;Noëlle Dufour;Noëlle Dufour

  250
  Citations

• Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington's disease.

  Doris C. V. Thu;Dorothy E. Oorschot;Lynette J. Tippett;Alissa L. Nana

  243
  Citations

• Altered chromatin architecture underlies progressive impairment of the heat shock response in mouse models of Huntington disease

  John Labbadia;Helen Cunliffe;Andreas Weiss;Elena Katsyuba

  209
  Citations

• HTT-lowering reverses Huntington’s disease immune dysfunction caused by NFκB pathway dysregulation

  Ulrike Träger;Ralph Andre;Nayana Lahiri;Anna Magnusson-Lind;Anna Magnusson-Lind

  201
  Citations

• HDAC4 Reduction: A Novel Therapeutic Strategy to Target Cytoplasmic Huntingtin and Ameliorate Neurodegeneration

  Michal Mielcarek;Christian Landles;Andreas Weiss;Amyaouch Bradaia

  193
  Citations

• MicroRNA-22 (miR-22) Overexpression Is Neuroprotective via General Anti-Apoptotic Effects and May also Target Specific Huntington"s Disease-Related Mechanisms

  Ana Jovicic;Julien Francisco Zaldivar Jolissaint;Roger Moser;Mariana de Fatima Silva Santos

  193
  Citations

• Biological and potential therapeutic roles of sirtuin deacetylases.

  D. M. Taylor;M. M. Maxwell;R. Luthi-Carter;A. G. Kazantsev

  192
  Citations

• What have we learned from gene expression profiles in Huntington's disease?

  Tamara Seredenina;Ruth Luthi-Carter

  189
  Citations

• A brain-permeable small molecule reduces neuronal cholesterol by inhibiting activity of sirtuin 2 deacetylase.

  David M. Taylor;Uma Balabadra;Zhongmin Xiang;Ben Woodman

  187
  Citations

• Neuroprotection by Hsp104 and Hsp27 in Lentiviral-based Rat Models of Huntington's Disease

  Valérie Perrin;Etienne Régulier;Toufik Abbas-Terki;Raymonde Hassig

  171
  Citations